CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Minapath is developing a diagnostic method to identify mineral exposure as a cause of various inflammatory and cancer conditions. This technology aims to improve the diagnosis of diseases often categorized as idiopathic by analyzing patients' exposure to harmful mineral dusts.
Today healthcare faces critical challenges coming from an ageing population and the rise of chronic diseases.
With a population expected to reach 9 billion people by 2050, healthcare expenditure is at risk of becoming unsustainable.
Sustainability requires diagnostic methods to become more efficient, fast and accurate, to facilitate the use of adequate therapy.
Despite the effort being made, there are still many diseases that get categorized as idiopathic (unknown cause).
Specially in the lung,…
MINAPATH DEVELOPPEMENT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
